رؤى السوق وآراء المحللين:
تُستخدم أنظمة توصيل الأدوية الرئوية لتوصيل الهباء الجوي مباشرة إلى الخلايا الظهارية وظهارة الجهاز التنفسي من خلال الاستنشاق. وتشمل الأنظمة أجهزة مثل أجهزة الاستنشاق والبخاخات لتوصيل الأدوية إلى الرئتين لعلاج المرضى المصابين بأمراض الجهاز التنفسي. تعتمد أجهزة توصيل الدواء الرئوي على آليات توصيل متنوعة وتحتوي على تركيبات دوائية مختلفة. يعد الربو وأمراض الانسداد الرئوي المزمن (COPD) والتهابات الجهاز التنفسي الحادة والتهاب الأنف التحسسي والتليف الكيسي من أمراض الجهاز التنفسي الرئيسية التي تتطلب استخدام أجهزة توصيل الدواء. إن العبء المتزايد لأمراض الجهاز التنفسي والمبادرات الإستراتيجية المتنامية من قبل الشركات تدعم نمو سوق أنظمة توصيل الأدوية الرئوية. تشمل اتجاهات سوق أنظمة توصيل الأدوية الرئوية التطورات في تقنيات أجهزة الاستنشاق التي من شأنها أن تدعم نمو السوق في المستقبل.
محركات النمو:
الشركات العاملة في سوق أنظمة توصيل الأدوية الرئوية باستمرار التركيز على التطورات الإستراتيجية مثل التعاون والاتفاقيات والشراكات وإطلاق المنتجات الجديدة. تساعدهم هذه الاستراتيجيات على تحسين مبيعاتهم وزيادة انتشارهم الجغرافي وتعزيز قدراتهم على خدمة قاعدة أكبر من العملاء الحاليين. يتم توجيه إطلاق المنتجات الجديدة بشكل أساسي نحو زيادة الأمان، والميزات سهلة الاستخدام، وقدرات الجرعات الأفضل، وما إلى ذلك، لجذب قاعدة كبيرة من المرضى. فيما يلي بعض التطورات الجديرة بالملاحظة في سوق أنظمة توصيل الأدوية الرئوية:
في سبتمبر 2021، حصلت شركة BreatheSuite Inc. على موافقة 510(K) من إدارة الغذاء والدواء الأمريكية (FDA) لجهاز الاستنشاق بالجرعات المقننة BreatheSuite. جهاز V1 للوصفات الطبية والاستخدام بدون وصفة طبية. يقوم جهاز BreatheSuite V1 بتحويل أجهزة الاستنشاق بالجرعات المقننة الموجودة إلى أجهزة استنشاق ذكية من خلال المراقبة التلقائية والدقيقة وتقديم تعليقات حول الالتزام بجهاز الاستنشاق وتقنياته لمرضى الربو ومرض الانسداد الرئوي المزمن. ، في المملكة المتحدة لعلاج مرض الانسداد الرئوي المزمن. في أبريل 2021، تعاونت KINDEVA DRUG DELIVERY مع Cambridge Healthcare Innovations Limited (CHI) لتطوير وتسويق تقنية منصة استنشاق المسحوق الجاف αeolus (DPI) من CHI. في ديسمبر 2020، AireHealth، وهي شركة صحية رقمية مبتكرة حصلت الشركة على تصريح 510 (ك) مقابل البخاخات المتصلة الخاصة بها. الجهاز عبارة عن بخاخة شبكية تهتز محمولة وإلكترونية. وهو مصمم لرذاذ الأدوية السائلة لاستنشاقها من قبل المريض. يتم تسويقه تحت اسم العلامة التجارية VitalMed. .وبالتالي، فإن العدد المتزايد من التطورات الإستراتيجية وإطلاق المنتجات من قبل الشركات لتظل قادرة على المنافسة في السوق يدفع نمو سوق أنظمة توصيل الأدوية الرئوية.
الرؤى الإستراتيجية
تقسيم التقرير ونطاقه:<
تم إجراء تحليل سوق أنظمة توصيل الأدوية الرئوية من خلال النظر في القطاعات التالية: المنتج، والمؤشر، وقناة التوزيع، والمستخدم النهائي، والجغرافيا. من حيث المنتج، يتم تقسيم السوق إلى أجهزة استنشاق المساحيق الجافة، والبخاخات، وأجهزة الاستنشاق بالجرعات المقننة. وبالدلالة، يصنف السوق إلى أمراض الانسداد الرئوي المزمن والربو والتليف الكيسي وغيرها. بناءً على قناة التوزيع، يتم تصنيف السوق إلى صيدليات المستشفيات وصيدليات البيع بالتجزئة والتجارة الإلكترونية. بناءً على المستخدم النهائي، ينقسم السوق إلى مستشفيات وعيادات ورعاية منزلية. يغطي نطاق تقرير سوق أنظمة توصيل الأدوية الرئوية أمريكا الشمالية (الولايات المتحدة وكندا والمكسيك) وأوروبا (فرنسا وألمانيا والمملكة المتحدة وإسبانيا وإيطاليا وبقية أوروبا) وآسيا والمحيط الهادئ (الصين واليابان والهند). وكوريا الجنوبية وأستراليا وبقية منطقة آسيا والمحيط الهادئ)، والشرق الأوسط وأفريقيا (المملكة العربية السعودية وجنوب أفريقيا والإمارات العربية المتحدة وبقية منطقة الشرق الأوسط وأفريقيا)، وأمريكا الجنوبية والوسطى (البرازيل والأرجنتين و بقية أمريكا الجنوبية والوسطى).
التحليل القطاعي:
يتم تصنيف سوق أنظمة توصيل الأدوية الرئوية، حسب المنتج، إلى أجهزة استنشاق المساحيق الجافة، والبخاخات، وأجهزة الاستنشاق بالجرعات المقننة. استحوذ قطاع أجهزة الاستنشاق بالمساحيق الجافة على حصة سوقية كبيرة في عام 2023. ومن المتوقع أن يسجل أعلى معدل نمو سنوي مركب في السوق خلال الفترة 2023-2031.
الحصة السوقية لأنظمة توصيل الأدوية الرئوية، حسب المنتج - 2023 و2031
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The global pulmonary drug delivery systems market is segmented based on product, indication, distribution channel, and end user. The pulmonary drug delivery systems market, by product, is categorized into dry powder inhalers, nebulizers, and metered dose inhalers. The dry powder inhalers segment held a significant market share in 2023 and is anticipated to record the highest CAGR in the market during 2023–2031.
The pulmonary drug delivery systems market was valued at US$ 49.71 billion in 2023.
The pulmonary drug delivery systems market is expected to be valued at US$ 73.14 billion in 2031.
The pulmonary drug delivery systems market majorly consists of the players, including AstraZeneca, GlaxoSmithKline Plc, Novartis AG, Koninklijke Philips NV, Boehringer Ingelheim International GmbH, Cipla Inc., OMRON Corp., PARI GmbH, Glenmark Pharmaceuticals, and Gilbert Technologies.
Pulmonary drug delivery refers to the systems that target the delivery of aerosols directly to epithelial cells and respiratory epithelium through inhalation. These systems deliver the drug to the lungs to treat respiratory diseases. It is one of the most preferred drug delivery routes and a noninvasive technique with a large surface area of absorption and blood circulation.
The factors driving the growth of the pulmonary drug delivery systems market include the increasing burden of respiratory diseases and growing strategic initiatives by companies. However, regulatory issues associated with the approval of pulmonary drug delivery systems hampers the growth of the pulmonary drug delivery systems market.
The List of Companies - Pulmonary Drug Delivery Systems Market
- AstraZeneca
- GlaxoSmithKline Plc
- Novartis AG
- Koninklijke Philips NV
- Boehringer Ingelheim International GmbH
- Cipla Inc
- OMRON Corp.
- PARI GmbH
- Glenmark Pharmaceuticals
- Gilbert Technologies
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Mar 2024
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Mar 2024
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2024
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2024
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2024
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2024
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2024
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Mar 2024
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)